Nan Fung Group Holdings Ltd

CIK: 0001782539Latest portfolio: $111.7M · Q4 2025

Holdings

27

Total Value

$111.7M

New Positions

4

Closed Positions

1

#StockSharesValue% PortfolioChangeType
1
EVMNEVOMMUNE INC
1,441,032$24.7M22.08%NEW
2
MPLTMAPLIGHT THERAPEUTICS INC
971,253$17.1M15.27%NEW
3
OCSOCULIS HOLDING AG
514,702$10.3M9.20%
4
MDGLMADRIGAL PHARMACEUTICALS INC
11,872$6.9M6.19%
5
LBRXLB PHARMACEUTICALS INC
300,000$6.7M5.98%
6
INCYINCYTE CORP
59,022$5.8M5.22%
7
RYTMRHYTHM PHARMACEUTICALS INC
49,120$5.3M4.71%
8
ONCBEONE MEDICINES LTD
15,722$4.8M4.27%
9
PCORPROCORE TECHNOLOGIES INC
53,299$3.9M3.47%NEW
10
HELPCYBIN INC
460,000$3.8M3.37%NEW
11
ASNDASCENDIS PHARMA A/S
13,600$2.9M2.60%
12
ACADACADIA PHARMACEUTICALS INC
102,984$2.8M2.46%
13
RXRXRECURSION PHARMACEUTICALS IN
595,287$2.4M2.18%
14
FLBSTANDARD BIOTOOLS INC
1,883,179$2.4M2.16%
15
KYMRKYMERA THERAPEUTICS INC
30,875$2.4M2.15%
16
ARGXARGENX SE
2,800$2.4M2.11%
17
RVMDREVOLUTION MEDICINES INC
19,253$1.5M1.37%
18
ETHAISHARES ETHEREUM TR
50,549$1.1M1.01%
19
HRMYHARMONY BIOSCIENCES HLDGS IN
27,049$1.0M0.91%
20
IBITISHARES BITCOIN TRUST ETF
15,968$792K0.71%
21
RANIRANI THERAPEUTICS HLDGS INC
493,584$666K0.60%
22
REPLREPLIMUNE GROUP INC
63,719$619K0.55%
23
TRDAENTRADA THERAPEUTICS INC
49,082$504K0.45%
24
BCYCBICYCLE THERAPEUTICS PLC
68,943$488K0.44%
25
BOLTBOLT BIOTHERAPEUTICS INC
58,347$319K0.29%

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
6RJ04K+-25716

Decreased Positions

No decreased positions

Sector Breakdown

Healthcare0.0% ($2.467017060102787e+72T)
Unknown0.0% ($2.4B)
Financial Services0.0% ($1.1B)
Technology0.0% ($387.6M)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 13, 2026$111.7M27
Q3 2025Nov 13, 2025$59.6B24
Q2 2025Aug 13, 2025$63.4B0
Q1 2025May 14, 2025$122.6B35
Q4 2024Feb 13, 2025$116.9B35

Fund Information

CIK0001782539
Most Recent FilingFeb 13, 2026
Number of Filings5

Nan Fung Group Holdings Ltd is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $111.7M across 27 holdings. The largest position is EVOMMUNE INC (EVMN), representing 22.1% of the portfolio. Compared to the previous quarter, the fund opened 4 new positions and closed 1 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.